Work for Predictive Oncology Inc.?

Claim Your Profile

Predictive Oncology Inc. Logo Image

Predictive Oncology Inc.

Predictive Oncology Inc. Banner Image

Most Recent Annual Report

Upgrade your company profile to unlock all of your annual report content on AnnualReports.com

2019 Annual Report and Form 10K

Predictive Oncology Inc.

Predictive Oncology Inc. has reached its limit for free report views.

About Predictive Oncology Inc.

11-50 Employees
Based in Eagan, Minnesota

Predictive Oncology (NASDAQ: POAI) operates through three segments (Domestic, International and other), which contain four subsidiaries; Helomics, TumorGenesis, Skyline Medical and Soluble Biotech. Helomics applies artificial intelligence to its rich data gathered from patient tumors to both personalize cancer therapies for patients and drive the development of new targeted therapies in collaborations with pharmaceutical companies. Helomics’ CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient treatment decisions, by providing an evidence-based roadmap for therapy. In addition to its proprietary precision oncology platform, Helomics offers boutique CRO services that leverage its TruTumor™, patient-derived tumor models coupled to a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered proprietary bioinformatics platform to provide a tailored solution to its clients’ specific needs.

Ticker:
POAI
Exchange:
NASDAQ (See More NASDAQ Companies)
Industry:
Medical Instruments & Supplies (See More Medical Instruments & Supplies Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol